Fluoxetine

K K Jain MD (Dr. Jain is a consultant in neurology and has no relevant financial relationships to disclose.)
Originally released June 30, 1999; last updated June 25, 2016; expires June 25, 2019

Historical note and terminology

Fluoxetine is a selective serotonin reuptake inhibitor. Serotonin, or 5-hydroxytryptamine, was discovered in 1948 and since then has played an increasing part in the understanding of human diseases, particularly those involving the nervous system (Rapport et al 1948). Demonstration of pharmacological manipulation to prevent selective reuptake led to the synthesis of fluoxetine for the treatment of depression (Wong et al 1974). It was introduced in 1988. The development of selective serotonin reuptake inhibitors was a major achievement in pharmacologic manipulation of this system. The use of fluoxetine has expanded to include other disorders as well.

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.